Cagrilintide × Certified Peptides - Lab Test, January 2026
Test results
About this test
This independent HPLC-UV/VIS lab test confirms Cagrilintide/Semaglutide 5mg/5mg from Certified Peptides at 99.67% purity. The assay measured 4.26 mg of Cagrilintide and 6.12 mg of Semaglutide per vial. The analysis was performed by Vanguard Laboratory and reported on January 30, 2026, under Lot Number 251227CS53.
Cagrilintide is a long-acting amylin receptor agonist, and Semaglutide is a GLP-1 receptor agonist. This combination is researched for its synergistic effects on appetite regulation, glycemic control, and weight management. Additional testing confirmed endotoxin levels below 5.00 EU/mg (LAL method), sterility with no growth detected (USP <71>), and non-detectable levels of heavy metals including chromium, arsenic, cadmium, lead, and mercury via ICP-MS.
The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.